1
A Study Comparing GLIADEL to Stereotactic Radiosurgery in Metastatic Brain Disease
Condition(s):Brain Tumor – MetastaticLast Updated:October 3, 2022Recruiting
Carmustine: 265 Clinical Trials, Page 1 of 27
Hide Studies Not Open or Pending
2
Dacarbazine and Carmustine in Metastatic Melanoma
Condition(s):Melanoma MetastaticLast Updated:April 4, 2018Terminated
3
Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma
Condition(s):Anaplastic Astrocytoma; Anaplastic Oligodendroglioma; Anaplastic Oligoastrocytoma; GlioblastomaLast Updated:August 3, 2012Unknown status
4
Gliadel Wafer and Fluorescence-Guided Surgery With 5-ALA Followed by Radiation Therapy And Temozolomide in Treating Patients With Primary Glioblastoma
Condition(s):GlioblastomaLast Updated:October 5, 2017Completed
5
Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma
Condition(s):Anaplastic Astrocytoma; Anaplastic Oligodendroglioma; Anaplastic Oligoastrocytoma; GlioblastomaLast Updated:July 11, 2012Unknown status
6
O6-Benzylguanine and Topical Carmustine in Treating Patients With Early-Stage IA-IIA Cutaneous T-Cell Lymphoma
Condition(s):Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma; Stage I Mycosis Fungoides and Sezary Syndrome AJCC v7; Stage II Mycosis Fungoides and Sezary Syndrome AJCC v7Last Updated:May 22, 2018Completed
7
O6-benzylguanine and Carmustine in Treating Patients With Stage IA-IIA Cutaneous T-cell Lymphoma
Condition(s):Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Stage I Cutaneous T-cell Non-Hodgkin Lymphoma; Stage II Cutaneous T-cell Non-Hodgkin LymphomaLast Updated:January 11, 2013Terminated
8
Gliadel Wafer and O6-Benzylguanine in Treating Patients With Recurrent Glioblastoma Multiforme
Condition(s):Recurrent Adult Brain TumorLast Updated:July 10, 2014Completed
9
Vigilant ObservatIon of GlIadeL WAfer ImplaNT Registry
Condition(s):CNS TumorLast Updated:June 30, 2022Active, not recruiting
10
NovoTTF-100A With Bevacizumab and Carmustine in Treating Patients With Glioblastoma Multiforme in First Relapse
Condition(s):Adult Brain Glioblastoma; Recurrent Adult Brain NeoplasmLast Updated:January 9, 2018Withdrawn